January 18, 2019

Deal Snapshot: Knight Therapeutics & Puma Biotechnology

Knight Therapeutics deal history per quarter.


  • Upfront: Undisclosed
  • Milestones: Undisclosed
  • Total Deal Value: USD 7.2M
  • Royalties: Double digit sales royalties
  • Territory: Canada

Knight Therapeutics Key BD Contacts

Knight Therapeutics Deal Activity by Therapeutic Area (Last 5 Years)

33% Oncology, 33% Gastrointestinal, 33% Immunology

Recent deals:


Business profiles tailored to your asset.